Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01394159 · ClinicalTrials.gov registry record · NA
22G FNA Needle vs. 22G ProCore Needle
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01394159 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 56 participants.
The verdict
NCT01394159, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The aim of this research study is to identify the best needle for performing biopsy during EUS procedures. There are two types of needles for performing biopsy: A FNA needle that provides a small sample of tissue for analysis and a 22G ProCore needle that provides larger amount of tissue. It is not clear at this point which of the two needles is superior for performing biopsy. This study will attempt to identify the better needle by assessing the performance of both needles in a randomized fashion.
Interventions
- PROCEDURE 22G ProCore biopsy needle
- PROCEDURE 22G standard FNA needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01394159
The ClinicalTrials.gov registry entry for NCT01394159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 22G ProCore biopsy needle is the first listed.
NCT01394159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01394159 about?
NCT01394159 is a clinical study titled "22G FNA Needle vs. 22G ProCore Needle". The aim of this research study is to identify the best needle for performing biopsy during EUS procedures. There are two types of needles for performing biopsy: A FNA needle that provides a small sample of tissue for analysis and a 22G ProCore needle that provides larger amount of tissue. It is not ...
What is the current status of trial NCT01394159?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2011-07. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01394159?
The interventions under investigation include: 22G ProCore biopsy needle (PROCEDURE), 22G standard FNA needle (PROCEDURE).
Who is sponsoring clinical trial NCT01394159?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.